461 related articles for article (PubMed ID: 2458717)
1. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin.
Alonso MT; Sanchez A; Garcia-Sancho J
Biochem J; 1990 Dec; 272(2):435-43. PubMed ID: 2125206
[TBL] [Abstract][Full Text] [Related]
3. Response of human platelets exposed to arachidonate upon stimulation with other agonists: possible role of Ca2+i movement.
Chen ZM; Cerletti C; de Gaetano G; Bertelé V
Biochem Biophys Res Commun; 1987 Dec; 149(3):1193-9. PubMed ID: 3122746
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
7. Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization.
Hatmi M; Rotilio D; Haye B; Antonicelli F; Joseph D; Vargaftig BB
Eur J Pharmacol; 1986 Dec; 132(2-3):219-28. PubMed ID: 3028837
[TBL] [Abstract][Full Text] [Related]
8. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
[TBL] [Abstract][Full Text] [Related]
9. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
10. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
11. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
12. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
Altman R; Scazziota A
Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757
[TBL] [Abstract][Full Text] [Related]
13. Synergistic potentiation of 5-hydroxytryptamine secretion by platelet agonists and phorbol myristate acetate despite inhibition of agonist-induced arachidonate/thromboxane and beta-thromboglobulin release and Ca2+ mobilization by phorbol myristate acetate.
Krishnamurthi S; Joseph S; Kakkar VV
Biochem J; 1986 Aug; 238(1):193-9. PubMed ID: 2948494
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets.
Murray R; Shipp E; FitzGerald GA
J Biol Chem; 1990 Dec; 265(35):21670-5. PubMed ID: 1701435
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Matthews JS; Jones RL
Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
Dutta-Roy AK; Ray TK; Sinha AK
Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ
Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclic AMP, iodide and metabolites of arachidonic acid in the regulation of cell proliferation of isolated porcine thyroid follicles.
Gärtner R; Greil W; Demharter R; Horn K
Mol Cell Endocrinol; 1985 Sep; 42(2):145-55. PubMed ID: 2998905
[TBL] [Abstract][Full Text] [Related]
20. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
